Ypsomed will make injection pens for Novo Nordisk's CagriSema, source says
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...
Ypsomed will make injection pens for Novo Nordisk's CagriSema, says source
Swiss medical technology company Ypsomed's contract with Novo Nordisk includes the supply of injection pens for the Danish ...
Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens
Novo Nordisk's (NVO) contract Ypsomed to supply the company with injection pens designed to deliver its next-gen obesity ...
Job boom creates Swiss immigration headache for EU trade talks
Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...
Ypsomed Holding (VTX:YPSN) Is Looking To Continue Growing Its Returns On Capital
If you haven't worked with ROCE before, it measures the 'return' (pre-tax profit) a company generates from capital employed in its business. To calculate this metric for Ypsomed Holding, this is the ...
Swiss-EU trade talks in jeopardy as immigration becomes political flashpoint
Switzerland is scrambling to keep a lid on immigration from its top trade partner, the European Union, as a jobs boom powered ...
Yahoo Finance6d
Ypsomed Holding AG (YPHDF)
Novo Nordisk and Ypsomed’s 2023 deal is rumoured to include an autoinjector supply for potential Wegovy successor CagriSema. The collaboration will integrate BD's Neopak XtraFlow glass prefillable ...
Yahoo Finance9d
Ypsomed Holding (VTX:YPSN) Is Looking To Continue Growing Its Returns On Capital
0.13 = CHF87m ÷ (CHF1.2b - CHF513m) (Based on the trailing twelve months to September 2024). So, Ypsomed Holding has an ROCE of 13%. That's a pretty standard return and it's in line with the industry ...